Dennis Smith
Pulmonary Disease · Baltimore, MDNPI 1386655074
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations.
Across 81 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$167
- Boehringer Ingelheim$164
- Mylan Specialty L.p.$129
- AstraZeneca$127
- Sunovion Pharmaceuticals Inc.$93
- Grifols USA, LLC$91
- plus $560 from 15 others
What the payments were for
- Food & beverage$1,31999%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 10 | $167 |
| Boehringer Ingelheim | 10 | $164 |
| Mylan Specialty L.p. | 10 | $129 |
| AstraZeneca | 9 | $127 |
| Sunovion Pharmaceuticals Inc. | 6 | $93 |
| Grifols USA, LLC | 5 | $91 |
| Genentech USA, Inc. | 3 | $70 |
| Sanofi | 3 | $68 |
| Bayer | 3 | $67 |
| Mallinckrodt Enterprises LLC | 3 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Electromed, Inc. | 3 | $39 |
| Shire North American Group Inc | 2 | $37 |
| Actelion Pharmaceuticals US, Inc. | 2 | $33 |
| Circassia Inc. | 2 | $31 |
| Advanced Respiratory, Inc | 2 | $26 |
| Merck | 2 | $22 |
| Philips North America LLC | 1 | $19 |
| Insmed, Inc. | 1 | $18 |
| Resmed Corp | 1 | $17 |
| Pfizer | 1 | $14 |
How this compares
$1,331 in reported general payments places this provider in the 55th percentile of 297 pulmonary disease providers in Maryland.
Other pulmonary disease in Baltimore
- Alan SchwartzBaltimore$1.3M
- Hitesh BatraBaltimore$611K
- Lonny YarmusBaltimore$582K
- Robert WiseBaltimore$389K
- Ko Pen WangBaltimore$280K
- Hans LeeBaltimore$277K
- Angela ArgentoBaltimore$269K
- Michael DrummondBaltimore$263K
- Jason AkulianBaltimore$231K
- Kathryn RobinettBaltimore$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.